Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: A systematic review

被引：121

作者：

Clerico, Aldo

Fontana, Marianna

Zyw, Luc

Passino, Claudio

Emdin, Michele

机构：

[1] CNR, Inst Clin Physiol, Lab Cardiovasc Endocrinol & Cell Biol, I-56126 Pisa, Italy

[2] CNR, Inst Clin Physiol, Lab Cardiovasc Endocrinol, I-56126 Pisa, Italy

[3] CNR, Inst Clin Physiol, Dept Cardiovasc Med, I-56126 Pisa, Italy

来源：

CLINICAL CHEMISTRY | 2007年 / 53卷 / 05期

关键词：

D O I：

10.1373/clinchem.2006.075713

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Background: We used evidence-based laboratory medicine principles to compare the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) assays for the diagnosis of heart failure. Methods: In May 2006, we performed a computerized literature search of the online National Library of Medicine to select studies specifically designed to compare the diagnostic accuracy of BNP and NT-proBNP assays. The comparison took into account the area under the curve and diagnostic odds ratio (DOR) derived from ROC analysis of original studies. Results: Both BNP and NT-proBNP assays were found to be clinically useful for the diagnosis of heart failure. Metaanalysis of these data was difficult because of the heterogeneity of data regarding patient population, diagnostic criteria, end-points, and immunoassay methods for both BNP and NT-proBNP. Separate metaanalyses were performed for acute and chronic heart failure. In chronic heart failure, the diagnostic DOR for BNP (8.44, 95% CI 4.66-15.30) was not significantly different from that of NT-proBNP (23.36, 95% CI 9.38-58.19). In patients with acute heart failure, the mean DOR for BNP (16.46, 95% CI 10.65-25.43) was not significantly different from that of NT-proBNP (18.61, 95% CI 12.99-26.65). Conclusion: Our results indicate that both BNP and NT-proBNP assays have a high degree of diagnostic accuracy and clinical relevance for both acute and chronic heart failure. (c) 2007 American Association for Clinical Chemistry.

引用

页码：813 / 822

页数：10

共 38 条

[1] Executive summary:: HFSA 2006 comprehensive heart failure practice guideline [J].

Adams, KF ;

Lindenfeld, J ;

Arnold, JMO ;

Baker, DW ;

Barnard, DH ;

Baughman, KL ;

Boehmer, JP ;

Deedwania, P ;

Dunbar, SB ;

Elkayam, U ;

Gheorghiade, M ;

Howlett, JG ;

Konstam, MA ;

Kronenberg, MW ;

Massie, BM ;

Mehra, MR ;

Miller, AB ;

Moser, DK ;

Patterson, JH ;

Rodeheffer, RJ ;

Sackner-Bernstein, J ;

Silver, MA ;

Starling, RC ;

Stevenson, LW ;

Wagoner, LE ;

Francis, GS ;

Bristow, MR ;

Cohn, JN ;

Colucci, WS ;

Greenberg, BH ;

Force, T ;

Krumholz, HM ;

Liu, PP ;

Mann, DL ;

Piña, IL ;

Pressler, SJ ;

Sabbah, HN ;

Yancy, CW .

JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) :10-38

[2] Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea [J].

Alibay, Y ;

Beauchet, A ;

El Mahmoud, R ;

Schmitt, C ;

Brun-Ney, D ;

Benoit, MO ;

Dubourg, O ;

Boileau, C ;

Jondeau, G ;

Puy, H .

BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (1-2) :20-24

[3] Quality specifications for B-type natriuretic peptide assays [J].

Apple, FS ;

Panteghini, M ;

Ravkilde, J ;

Mair, J ;

Wu, AHB ;

Tate, J ;

Pagani, F ;

Christenson, RH ;

Jaffe, AS .

CLINICAL CHEMISTRY, 2005, 51 (03) :486-493

[4] B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress [J].

Bal, L ;

Thierry, S ;

Brocas, E ;

Van de Louw, A ;

Pottecher, J ;

Hours, S ;

Moreau, MH ;

Gachadoat, DP ;

Tenaillon, A .

ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2006, 50 (03) :340-347

[5] Diagnostic ability of B-type natriuretic peptide and impedance cardiography: Testing to identify left ventricular dysfunction in hypertensive patients [J].

Bhalla, V ;

Isakson, S ;

Bhalla, MA ;

Lin, JP ;

Clopton, P ;

Gardetto, N ;

Maisel, AS .

AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (02) :73S-81S

[6]

BOYD JC, 2003, EVIDENCE BASED LAB M, P115

[7] Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: Comparison with brain natriuretic peptide (BNP) [J].

Chenevier-Gobeaux, C ;

Claessens, YE ;

Voyer, S ;

Desmoulins, D ;

Ekindjian, OGJC .

CLINICA CHIMICA ACTA, 2005, 361 (1-2) :167-175

[8] Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP [J].

Chien, Tzu-I ;

Chen, Hui-hou ;

Kao, Jau-Tsuen .

CLINICA CHIMICA ACTA, 2006, 369 (01) :95-99

[9] Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications [J].

Clerico, A ;

Recchia, FA ;

Passino, C ;

Emdin, M .

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (01) :H17-H29

[10] Analytical performance and diagnostic accuracy of immunometric assays for the measurement of plasma B-type natriuretic peptide (BNP) and N-terminal proBNP [J].

Clerico, A ;

Prontera, C ;

Emdin, M ;

Passino, C ;

Storti, S ;

Poletti, R ;

Zyw, L ;

Zucchelli, GC .

CLINICAL CHEMISTRY, 2005, 51 (02) :445-447

← 1 2 3 4 →